Search

Your search keyword '"Attardi LD"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Attardi LD" Remove constraint Author: "Attardi LD"
135 results on '"Attardi LD"'

Search Results

1. Erratum.

2. Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants

4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

5. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

6. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

8. Loss of the desmosomal component Perp impairs wound healing in vivo.

9. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

10. Activating p53 Y220C with a Mutant-Specific Small Molecule.

11. Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network.

12. Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.

13. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.

14. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

16. Epigenetic priming targets tumor heterogeneity to shift transcriptomic phenotype of pancreatic ductal adenocarcinoma towards a Vitamin D susceptible state.

17. p53 governs an AT1 differentiation programme in lung cancer suppression.

18. p53 promotes revival stem cells in the regenerating intestine after severe radiation injury.

19. Multifaceted role for p53 in pancreatic cancer suppression.

20. The p53 Transactivation Domain 1-Dependent Response to Acute DNA Damage in Endothelial Cells Protects against Radiation-Induced Cardiac Injury.

21. The Mettl3 epitranscriptomic writer amplifies p53 stress responses.

22. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications.

23. A p53-dependent translational program directs tissue-selective phenotypes in a model of ribosomopathies.

24. The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling.

25. Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects.

26. Zmat3 splices together p53-dependent tumor suppression.

27. An anterograde pathway for sensory axon degeneration gated by a cytoplasmic action of the transcriptional regulator P53.

28. p53 and Tumor Suppression: It Takes a Network.

29. Cell of Origin Influences Pancreatic Cancer Subtype.

30. Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.

31. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR).

32. P53 orchestrates a complex symphony of cellular processes during oncosuppression.

33. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

34. p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygen.

35. Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.

36. Siva plays a critical role in mouse embryonic development.

37. SIDT2 RNA Transporter Promotes Lung and Gastrointestinal Tumor Development.

38. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I.

39. The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes.

40. The role of p53 in developmental syndromes.

41. Mutations in PERP Cause Dominant and Recessive Keratoderma.

42. Single Cell Transcriptomics Reveal Abnormalities in Neurosensory Patterning of the Chd7 Mutant Mouse Ear.

43. Deciphering p53 signaling in tumor suppression.

44. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.

45. p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells.

46. Deconstructing networks of p53-mediated tumor suppression in vivo.

47. Neat-en-ing up our understanding of p53 pathways in tumor suppression.

48. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer.

49. Neat1 is a p53-inducible lincRNA essential for transformation suppression.

50. The p53 family members have distinct roles during mammalian embryonic development.

Catalog

Books, media, physical & digital resources